Avidity Biosciences, Inc. (RNA) has 14 open-market insider trades by 6 insiders since 2020. The most active filer is Arthur A. Levin, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RTW Investments, L.P. | Dir10% Owner | — | 1 | $17.1M | 2020-06-16 |
| Roderick Wong | CIO10% Owner | — | 1 | $14.4M | 2021-08-04 |
| Arthur A. Levin | Dir | — | 8 | $6.4M | 2026-01-21 |
| Cormorant Private Healthcare Fund II, LP | Dir10% Owner | — | 1 | $5.4M | 2020-06-16 |
| Sarah Boyce | Dir | — | 2 | $2.3M | 2026-09-18 |
| Tamar Thompson | Dir | — | 1 | $1.3M | 2025-06-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sarah Boyce | President | Sell | $1.0M | 2026-01-21 |
| Steven George Hughes | Chief Medical Officer | Sell | $355K | 2026-01-21 |
| Arthur A. Levin | Director | Sell | $127K | 2026-01-21 |
| Michael F. MacLean | CFO | Sell | $329K | 2026-01-21 |
| W. Michael Flanagan | Chief Scientific Officer | Sell | $473K | 2026-01-21 |
| Teresa McCarthy | Chief Human Resources Officer | Sell | $212K |
Companies that share insiders with RNA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-01-21 |
| W. Michael Flanagan | Chief Scientific Officer | Sell | $171K | 2026-01-07 |
| Michael F. MacLean | CFO | Sell | $143K | 2026-01-07 |
| Charles Calderaro III | Chief Technical Officer | Sell | $269K | 2026-01-07 |
| Sarah Boyce | President | Sell | $619K | 2026-01-07 |
| Teresa McCarthy | Chief Human Resources Officer | Sell | $142K | 2026-01-07 |
| John B. Moriarty | CLO | Sell | $171K | 2026-01-07 |
| Steven George Hughes | — | Sell | $210K | 2025-10-22 |
| Teresa McCarthy | CHRO | Sell | $1.0M | 2025-10-15 |
| Eric Mosbrooker | CCO | Sell | $596K | 2025-10-03 |